FDA Inspection 1267405 — Oman Pharmaceutical Products Co. LLC
The FDA completed an inspection of Oman Pharmaceutical Products Co. LLC on January 25, 2023 in Central Salalah. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- January 25, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Central Salalah (Oman)
Additional Details
Mutual Recognition Agreement (MRA)